Clinical Trial Update: Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) [Phase 2]

View source ↗

Summary

Phase 2 study update on lenacapavir combined with emtricitabine/tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis in people who inject drugs. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: Pre-Exposure Prophylaxis of HIV Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING